Evaluation of alternative type iii lipid formulations which can be designated as superior carrier to improve solubility and availability of anti cholesterol drug fenofibrate for absorption
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Poster
- By: KAZI, Mohsin (King Saud University, Pharmaceutics, Riyadh, Saudi Arabia)
- Co-author(s): Alanazi, Fars (King Saud University, Riyadh, Saudi Arabia)
Background: LFCS (Lipid Formulation Classification Systems) Type III formulation systems within lipid based formulations have generated significant attention as they are considered as nano carriers for the delivery of poorly water soluble drugs. Aims: To investigate the aspects which can influence the design of successful LFCS alternative Type III .. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.